These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 34146432)

  • 1. Usefulness of extended-release topiramate in patients with epilepsy: A two-year retention study.
    Lee H; Kim DW
    J Clin Pharm Ther; 2021 Oct; 46(5):1412-1417. PubMed ID: 34146432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetic simulations of topiramate plasma concentrations following dosing irregularities with extended-release vs. immediate-release formulations.
    Brittain ST; Wheless JW
    Epilepsy Behav; 2015 Nov; 52(Pt A):31-6. PubMed ID: 26409125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Real-world assessment of treatment with extended-release topiramate (Trokendi XR
    O'Neal W; Hur EE; Liranso T; Patel B
    J Comp Eff Res; 2018 Nov; 7(11):1095-1105. PubMed ID: 30136603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lamotrigine extended-release as adjunctive therapy with optional conversion to monotherapy in older adults with epilepsy.
    Wechsler RT; Leroy R; Van Cott A; Hammer AE; Vuong A; Huffman R; VanLandingham K; Messenheimer JA
    Epilepsy Res; 2014 Aug; 108(6):1128-36. PubMed ID: 24888248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topiramate Extended Release: A Review in Epilepsy.
    Hoy SM
    CNS Drugs; 2016 Jun; 30(6):559-66. PubMed ID: 27224993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic factors affecting long-term retention of topiramate in patients with chronic epilepsy.
    Lhatoo SD; Wong IC; Sander JW
    Epilepsia; 2000 Mar; 41(3):338-41. PubMed ID: 10714407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy, safety, and tolerability of brivaracetam with concomitant lamotrigine or concomitant topiramate in pooled Phase III randomized, double-blind trials: A post-hoc analysis.
    Benbadis S; Klein P; Schiemann J; Diaz A; Elmoufti S; Whitesides J
    Epilepsy Behav; 2018 Mar; 80():129-134. PubMed ID: 29414542
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Changes in cognition after introduction or withdrawal of zonisamide versus topiramate in epilepsy patients: A retrospective study using Bayes statistics.
    Meschede C; Witt JA; Brömling S; Moskau-Hartmann S; Rademacher M; Surges R; von Wrede R; Helmstaedter C
    Epilepsia; 2020 Jul; 61(7):1481-1490. PubMed ID: 32557579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical effectiveness, tolerability and cost-effectiveness of newer drugs for epilepsy in adults: a systematic review and economic evaluation.
    Wilby J; Kainth A; Hawkins N; Epstein D; McIntosh H; McDaid C; Mason A; Golder S; O'Meara S; Sculpher M; Drummond M; Forbes C
    Health Technol Assess; 2005 Apr; 9(15):1-157, iii-iv. PubMed ID: 15842952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A randomized, open-label, multicenter comparative trial of levetiracetam and topiramate as adjunctive treatment for patients with focal epilepsy in Korea.
    Lee SK; Lee SA; Kim DW; Loesch C; Pelgrims B; Osakabe T; Lee B;
    Epilepsy Behav; 2019 Aug; 97():67-74. PubMed ID: 31195326
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topiramate in refractory epilepsy: a prospective observational study.
    Stephen LJ; Sills GJ; Brodie MJ
    Epilepsia; 2000 Aug; 41(8):977-80. PubMed ID: 10961624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term effects of levetiracetam and topiramate in clinical practice: A head-to-head comparison.
    Bootsma HP; Ricker L; Diepman L; Gehring J; Hulsman J; Lambrechts D; Leenen L; Majoie M; Schellekens A; de Krom M; Aldenkamp AP
    Seizure; 2008 Jan; 17(1):19-26. PubMed ID: 17618131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Practical aspects of the use of topiramate in patients with epilepsy.
    Sander JW
    Epilepsia; 1997; 38 Suppl 1():S56-8. PubMed ID: 9092962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of adjunctive topiramate on cognitive function in patients with epilepsy.
    Lee S; Sziklas V; Andermann F; Farnham S; Risse G; Gustafson M; Gates J; Penovich P; Al-Asmi A; Dubeau F; Jones-Gotman M
    Epilepsia; 2003 Mar; 44(3):339-47. PubMed ID: 12614389
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
    Lhatoo SD; Wong IC; Polizzi G; Sander JW
    Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The application of half-life in clinical decision making: Comparison of the pharmacokinetics of extended-release topiramate (USL255) and immediate-release topiramate.
    Gidal BE; Clark AM; Anders B; Gilliam F
    Epilepsy Res; 2017 Jan; 129():26-32. PubMed ID: 27883934
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topiramate monotherapy in the treatment of newly or recently diagnosed epilepsy.
    Ben-Menachem E; Sander JW; Stefan H; Schwalen S; Schäuble B
    Clin Ther; 2008 Jul; 30(7):1180-95. PubMed ID: 18691980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug-resistant epilepsy and topiramate: Plasma concentration and frequency of epileptic seizures.
    Marques FA; Albuquerque NCP; Campos MSA; Freitas-Lima P; Baldoni AO; Alexandre Júnior V; Sakamoto AC; Oliveira ARM; Pereira LRL
    Clin Exp Pharmacol Physiol; 2018 Jul; 45(7):652-658. PubMed ID: 29424067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.
    Sunwoo JS; Park BS; Ahn SJ; Hwang S; Park CY; Jun JS; Kim DW; Lee ST; Jung KH; Park KI; Chu K; Jung KY; Lee SK
    Clin Neuropharmacol; 2017; 40(2):56-62. PubMed ID: 28118167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative steady-state pharmacokinetic evaluation of immediate-release topiramate and USL255, a once-daily extended-release topiramate formulation.
    Bialer M; Shekh-Ahmad T; Braun TL; Halvorsen MB
    Epilepsia; 2013 Aug; 54(8):1444-52. PubMed ID: 23692553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.